Skip to content

HEALTH ADVANCE INC.: 10-Q filed 2014-03-17

What HEALTH ADVANCE INC. reported in its quarterly report filed 2014-03-17 (fiscal Q2 2014): 14 published measures, 41 facts as tagged in accession 0001213900-14-001472.

This filing

Form
10-Q (quarterly report)
Filed
2014-03-17
Fiscal period
fiscal Q2 2014
Accession
0001213900-14-001472 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HEALTH ADVANCE INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-01-31211USD
At 2013-07-31526USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-01-3178,434USD
At 2013-07-3158,787USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-01-31-78,223USD
At 2013-07-31-58,261USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-01-31211USD
At 2013-07-31526USD
At 2013-01-31281USD
At 2012-07-311,202USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-11-01 to 2014-01-31-16,621USD92
2013-08-01 to 2014-01-31-35,962USD184
2010-04-15 to 2014-01-31-299,323USD1388
2012-11-01 to 2013-01-31-35,436USD92
2012-08-01 to 2013-01-31-46,540USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-08-01 to 2014-01-31-18,601USD184
2010-04-15 to 2014-01-31-100,573USD1388
2012-08-01 to 2013-01-31-16,321USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-08-01 to 2014-01-3118,286USD184
2010-04-15 to 2014-01-31100,784USD1388
2012-08-01 to 2013-01-3115,400USD184

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-11-01 to 2014-01-3116,577USD92
2013-08-01 to 2014-01-3135,753USD184
2010-04-15 to 2014-01-31298,563USD1388
2012-11-01 to 2013-01-3135,307USD92
2012-08-01 to 2013-01-3146,411USD184

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2010-04-15 to 2014-01-3131USD1388

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2010-04-15 to 2014-01-3169USD1388

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-01-3124,520,000shares
At 2013-07-3124,520,000shares
At 2013-02-142,452,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-01-31156,080USD
At 2013-07-31144,080USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-11-01 to 2014-01-311,222USD92
2013-08-01 to 2014-01-314,968USD184
2010-04-15 to 2014-01-3127,001USD1388
2012-11-01 to 2013-01-315,707USD92
2012-08-01 to 2013-01-316,849USD184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-08-01 to 2014-01-314,000USD184
2010-04-15 to 2014-01-3152,100USD1388
2012-08-01 to 2013-01-3110,000USD184

Inspect the source

Entity
HEALTH ADVANCE INC. / CIK 0001531477
Captured
SEC response SHA-256
a550065778589cc9c6a547e2e2cade1051c212ba8e1708f6de17e309adc2340a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001531477.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))